Ebit تغيير تاريخ
Acadia Pharmaceuticals USD 6.99M 24.66M 2024-12
ALKERMES USD 162.69M 46.46M 2024-12
Alnylam Pharmaceuticals USD -105159000 28.25M 2024-12
Biogen USD 644.1M 100.9M 2024-12
BioMarin Pharmaceutical USD 161.41M 47.51M 2024-12
Bristol-Myers Squibb USD 4.18B 30M 2025-03
Corcept Therapeutics USD 25.26M 20.34M 2024-12
Cytokinetics USD -139040000 1.76M 2024-12
Eisai JPY 18.98B 12.87B 2024-03
Eli Lilly USD 3.7B 1.93B 2025-03
Incyte USD 283.64M 92.62M 2025-03
J&J USD 7.39B 2.04B 2025-03
Moderna USD -963000000 283M 2025-03
Neurocrine Biosciences USD 142M 41.8M 2024-12
Pfizer USD 5.93B 1.31B 2025-03
Prothena USD -64897000 1.62M 2024-12
PTC Therapeutics USD -162389000 107.88M 2024-12
Sarepta Therapeutics USD 161.68M 139.48M 2024-12
Ultragenyx Pharmaceutical USD -122278000 9.71M 2024-12
Vertex Pharmaceuticals USD 1.2B 108.8M 2024-12



Acadia Pharmaceuticals - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - May 2025.